Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
Lancet Haematol
; 10(8): e612-e623, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37385272
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tranexamic Acid
/
Von Willebrand Diseases
/
Menorrhagia
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Qualitative_research
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Lancet Haematol
Year:
2023
Document type:
Article
Country of publication:
United kingdom